Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00701870

Public ClinicalTrials.gov record NCT00701870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintra™, TLK199 Tablets) for Treatment of Chemotherapy Induced Neutropenia in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving First-Line Chemotherapy

Study identification

NCT ID
NCT00701870
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Telik
Industry
Enrollment
1 participant

Conditions and interventions

Interventions

  • ezatiostat hydrochloride (Telintra®) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
Oct 31, 2008
Completion
Oct 31, 2008
Last update posted
Nov 26, 2013

2008

United States locations

U.S. sites
24
U.S. states
9
U.S. cities
23
Facility City State ZIP Site status
Central Hematology Oncology Medical Group Alhambra California 91801
Pacific Cancer Medical Center, Inc. Anaheim California 92801
Providence St. Joseph Medical Center Burbank California 91505
St. Jude Heritage Healthcare Fullerton California 92835
Wilshire Oncology Medical Group La Verne California 91750
UCLA Medical Center Los Angeles California 90095
Clinical Trials and Research Associates, Inc. Montebello California 90640
North Valley Hematology/Oncology Medical Group Northridge California 91325
Ventura County Hematology-Oncology Specialists Oxnard California 93030
Samsum Clinic Santa Barbara California 93105
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105
Central Coast Medical Oncology Corporation Santa Maria California 93454
Broward Oncology Associates Fort Lauderdale Florida 33308
Nature Coast Clinical Research Inverness Florida 34452
Lakeland Regional Cancer Center Lakeland Florida 33805
Florida Hospital Cancer Institute Ormand Beach Florida 32174
Suburban Hematology-Oncology Associates, PC Lawrenceville Georgia 30045
Medical & Surgical Specialists Galesburg Illinois 61401
Joliet Oncology/Hematology Associates, Ltd. Joliet Illinois 60435
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052
Montefiore Medical Center The Bronx New York 10467
Case Medical Center-University Hospitals Cleveland Ohio 44106
The University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Coastal Cancer Center Myrtle Beach South Carolina 29572-4128

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00701870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00701870 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →